Forty years after Horst Bickel first treated a patient suffering from
phenylketonuria (PKU) our aim is to assess the current treatment of Au
strian patients. A total of 70 children - 60 with PKU and 10 with hype
rphenylalaninaemia (HPA)- aged 6-16 years were investigated in terms o
f somatic and intellectual parameters. Their development is normal (PK
U: mean IQ = 95.40; HPA: mean IQ = 101.85) owing to strict dietary con
trol, above all during their first 6 years of life. A comparison of th
e IQ data of 17 PKU children and their healthy siblings at the age 6 y
ears showed significant correlations in verbal, performance and IQ mea
surements. Austrian PKU patients do achieve normal IQ values but these
measurements fail to guarantee the quality of dietary control. IQ is
influenced by a number of variables: genetic, social environment, educ
ation and furtherance, motivation for performance, etc., and, in PKU p
atients, dietary control. The only currently known way of maintaining
and improving dietary compliance in PKU patients and their families re
mains good informative counselling about the disease and psychosocial
support.